Retour
Fourchette du Jour
10,74 €
11,74 €
Fourchette 52 Semaines
4,85 €
14,39 €
Volume
1 093 291
Moyenne 50J / 200J
11,16 €
/
9,67 €
Clôture Précédente
10,64 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -34,4 | 0,2 |
| P/B | 8,0 | 3,0 |
| ROE % | -30,2 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
19,25 €
+68.3%
Low: 16,00 €
High: 24,00 €
BPA Prévisionnel
-0,45 €
CA Est.
1,10M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,88 €
0,88 € – 0,88 €
|
416,69M | 3 |
| FY2029 |
-0,33 €
-0,33 € – -0,33 €
|
135,55M | 3 |
| FY2028 |
-0,58 €
-1,24 € – 1,12 €
|
31,87M | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-17 | -0,10 € | -0,06 € | +37,9% |
| 2025-11-13 | -0,10 € | -0,08 € | +20,0% |
| 2025-08-07 | -0,10 € | -0,09 € | +10,0% |
| 2025-05-08 | -0,13 € | -0,09 € | +30,8% |
| 2025-03-18 | -0,12 € | -0,11 € | +8,3% |
| 2024-11-06 | -0,12 € | -0,13 € | -8,3% |
| 2024-08-08 | -0,11 € | -0,12 € | -9,1% |
| 2024-05-07 | -0,09 € | -0,11 € | -22,2% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -42,10M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-30,23%
ROIC-20,11%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio19,66
Interest Coverage0,00
Valorisation
P/E Ratio
-34,35
Forward P/EN/A
P/B Ratio8,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -42,76M |
| ROE | -30,23% | ROA | -22,10% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -42,10M |
| ROIC | -20,11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 19,66 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -34,35 | Forward P/E | N/A |
| P/B Ratio | 8,02 | P/S Ratio | N/A |
| PEG Ratio | 1,11 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1338,07 | Fwd Earnings Yield | N/A |
| FCF Yield | -2,87% | ||
| Market Cap | 1,47B | Enterprise Value | 1,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -42,76M | -47,91M | -29,07M | -29,15M | -33,94M |
| EPS (Diluted) | -0,29 | -0,47 | -0,29 | -0,45 | -1,49 |
| Gross Profit | -132 000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -49,33M | -51,52M | -33,92M | -29,91M | -32,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 193,44M | 110,90M | 89,40M | 123,02M | 38,48M |
| Total Liabilities | 10,20M | 11,26M | 6,86M | 15,56M | 21,40M |
| Shareholders' Equity | 183,24M | 99,64M | 82,55M | 107,46M | 17,08M |
| Total Debt | 753 000,0 | 1,03M | 1,34M | 9,18M | 14,63M |
| Cash & Equivalents | 18,91M | 34,10M | 32,40M | 12,59M | 36,83M |
| Current Assets | 191,66M | 109,43M | 87,55M | 122,62M | 37,96M |
| Current Liabilities | 9,75M | 10,51M | 5,82M | 13,40M | 12,72M |